A Review of Bronchial Asthma: Diagnosis and Treatment

Authors

  • Rongala Manikanta Kumar Research Scholar, Emmanuel College of Pharmacy, Tagarapuvalasa, Visakhapatnam.

Keywords:

Bronchial asthma, airway inflammation, spirometry, inhaled corticosteroids, bronchodilators, asthma control, inhaler technique, pharmacist

Abstract

Bronchial asthma is a common chronic respiratory disease characterized by variable respiratory symptoms and variable expiratory airflow limitation. Patients may experience wheezing, coughing, chest tightness, and shortness of breath, with symptoms varying over time and often worsening at night, in the early morning, or following exposure to specific triggers. Asthma develops through a complex interaction of genetic susceptibility, environmental exposures, and airway inflammation. Inflammation, bronchial smooth muscle contraction, excessive mucus production, and airway wall swelling contribute to airflow obstruction. In some patients, persistent inflammation may lead to structural changes in the airways, known as airway remodeling.  The diagnosis of bronchial asthma is based on a compatible clinical history and objective evidence of variable expiratory airflow limitation, most commonly assessed through spirometry with bronchodilator reversibility testing. Peak expiratory flow monitoring, fractional exhaled nitric oxide (FeNO) measurement, and allergy testing may provide additional diagnostic information when interpreted in the appropriate clinical context. The primary objectives of asthma treatment are to achieve good symptom control, maintain normal physical activity and lung function, and minimize the risk of exacerbations and treatment-related adverse effects. Inhaled corticosteroid-containing medications play a central role in asthma management because they control underlying airway inflammation. Short-acting bronchodilators provide rapid relief of symptoms but do not adequately treat airway inflammation when used alone. Other therapeutic options include leukotriene receptor antagonists, long-acting muscarinic antagonists, short courses of oral corticosteroids for selected severe exacerbations, and biologic therapies for patients with appropriately assessed severe asthma. Patient education, proper inhaler technique, medication adherence, trigger avoidance, and regular clinical monitoring are essential components of effective asthma management. Pharmacists play an important role in asthma care by educating patients about controller and reliever medications, demonstrating correct inhaler techniques, identifying excessive reliever medication use, and promoting medication adherence. This review article discusses the overview of bronchial asthma, its risk factors, pathophysiology, classification, diagnosis, treatment approaches, complications, and the role of pharmacists in the effective management of bronchial asthma.

Downloads

Download data is not yet available.

Downloads

Published

2026-09-30

How to Cite

Rongala, M. K. (2026). A Review of Bronchial Asthma: Diagnosis and Treatment. Contemporary Research in Pharmacy Practice, 1(1), 12–16. Retrieved from https://cognixpress.in/index.php/crpp/article/view/93